STOCK TITAN

54,508-share option exercise filed for AVTX (NASDAQ: AVTX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AVTX-related sale notice: A broker-dealer filing lists 54,508 shares of Common Stock to be sold on 05/06/2026 pursuant to an exercise of stock options for cash. The filing also lists recent 10b5-1 programmed sales by Mittie Doyle totaling multiple transactions during March–May 2026.

Positive

  • None.

Negative

  • None.

Insights

Filing reports an issuer-directed option exercise and automated 10b5-1 sales.

The notice documents 54,508 shares offered on 05/06/2026 via exercise of options with cash consideration. It also lists multiple 10b5-1 sales by Mittie Doyle in Mar–May 2026, including a 25,492-share sale on 03/16/2026.

Regulatory implications are routine: these are transactional disclosures required under resale rules. Future filings would show settlement or any additional programmed sales.

Shares to be sold 54,508 shares to be sold on 05/06/2026 via exercise of stock options
Associated cash figure $886,300.08 cash amount listed on the same securities row
Recent 10b5-1 sale example 25,492 shares sale on 03/16/2026 by Mittie Doyle (proceeds shown $411,606.58)
Additional 10b5-1 sale 3,970 shares sale on 04/06/2026 by Mittie Doyle (proceeds shown $71,508.43)
Aggregate reference number 22,788,452 numeric field present in the securities row (context label not specified)
10b5-1 regulatory
"10b5-1 Sales for MITTIE DOYLE 1500 Liberty Ridge Drive"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Common | 05/06/2026 | Exercise of Stock Options | Issuer"
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the AVTX Form 144 say about the 05/06/2026 sale?

It states 54,508 shares of Common Stock are to be sold on 05/06/2026 via exercise of stock options. The filing lists the method as an exercise of stock options with cash consideration, reported through a broker-dealer.

Who executed recent 10b5-1 sales shown in the filing for AVTX?

The filing shows multiple programmed plan sales by Mittie Doyle during Mar–May 2026. Transactions include a 25,492-share sale on 03/16/2026 and other sales in April and May 2026.

How much cash proceeds are listed alongside the 54,508 shares in the filing?

The record includes a cash figure of $886,300.08 associated with the listed securities row. The filing pairs 54,508 shares with that cash figure in its summary line.

Does this Form 144 indicate who receives the sale proceeds for AVTX?

The filing labels the method as an exercise of stock options and identifies Issuer in the row, indicating cash consideration related to the option exercise. Specific payee allocation beyond that is not detailed.